Merck KGaA and Pfizer's Phase III JAVELIN Renal 101 trial, which will ...
Dr Reddy's Laboratories and XenoPort has announced that they have ente...
The International Training Course is being organized by the National B...
New Page 1 DBT to shepherd India Pavilion at BOSTON BIO ...
The collaboration provides up to $200 million in equity investments, m...
A study that was conducted on 12 MS patients using human embryonic ste...
Dell Services unveiled a cloud-based solution that seamlessly and cost...
Dr Reddy's Laboratories has announced that it has completed the purcha...
Eisai expands India presence Eisai, a pharma major...
Indian Immunologicals (IIL), a leading biologicals company in India, h...
Ms Kavitha Iyer Rodrigues, director and COO, Theramyt Novobiologics201...
Children's Hospital at Erlanger (Chattanooga, Tenn.) recently implemen...
Lupin Pharmaceuticals has received final approval for its Levonorgestr...
June 2004 Pharmaceutical Growth & Profitability Summit SR in...
Dr Rajneesh Kumar Gaur is Scientist C at the De...
Market for Real Market for Real-time PCRs soaring in In...
On the occasion of the 38th annual day celebration of the National Ins...
Glenmark Pharmaceuticals (Glenmark) has been granted final approval by...
